email

Dear Principle Investigators,

The National Cancer Institute (NCI) will host a virtual workshop, entitled ‘NCI Drug Development Workshop: How to Advance A Therapeutic Candidate from Bench to Bedside.’ This workshop will encompass a series of 10 webinar-based lectures delivered between July 23, 2021 and December 10, 2021 on selected Friday afternoons (per Eastern Time Zone). Each lecture will be approximately 2.5 hours duration, on discrete topics covering critical components necessary for advancing candidate therapeutics through the IND-enabling stage of drug development (i.e. to go from bench to bedside), in addition to lectures capturing funding resources, private sector considerations, and case studies of success. Each lecture will be delivered by a subject matter expert selected from the leading ranks of academic, public, and private sector settings.

This event is free and open to the public. The intended audience is translational scientists who are interested in learning about advancing the development of candidate therapeutics towards the clinic for cancer treatment. Junior faculty, staff, and trainees are encouraged to attend this workshop. Lectures will be accompanied by a facilitated discussion, and audience participation is highly encouraged.

Visit Agenda for more information about this workshop, and Registration is now open. You may register for individual sessions of interest to you.

Thank you and best regards,

The Workshop Planning Committee

Weiwei Chen, Ph.D., Program Director, PTGB, DTP, NCI

Rachelle Salomon, Ph.D., Program Director, BRB, DTP, NCI

Sharad Verma, Ph.D., Program Director, PTGB, DTP, NCI

Jason Yovandich, Ph.D., Chief, BRB, DTP, NCI

Sundar Venkatachalam, Ph.D., Chief, PTGB, DTP, NCI

Rose Aurigemma, Ph.D., Acting Associate Director, DTP, NCI

DTP: Developmental Therapeutics Program

PTGB: Pre-Clinical Therapeutics Grants Branch

BRB: Biological Resources Branch